Hi Oxxa,
10 patient for the expansion, in the original presentation said there were 32 sites so seems like it should happen quickly, is a pretty specific indication though.
Imugene have it now completing enrolment Q3 rather than Q2 (Q2 was in initial presentation). So 32 sites probably doesn’t speed it up as much as I’d like..
The clinical trial number estimates seem to be consistently misleading and just a range/max. Checkvacc is a good example of that.
Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial, page-194
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
